Sumitomo Mitsui Trust Group
CBMG

Sumitomo Mitsui Trust Group’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-476,673
Closed -$7.54M – 1161
2020
Q1 		$7.54M Sell
476,673
-56,152
-11% -$907K 0.01% 745
2019
Q4 		$8.65M Sell
532,825
-24,927
-4% -$416K 0.01% 756
2019
Q3 		$8.29M Buy
557,752
+29,334
+6% +$395K 0.01% 743
2019
Q2 		$8.73M Buy
528,418
+145,616
+38% +$2.38M 0.01% 729
2019
Q1 		$6.62M Buy
+382,802
New +$6.95M 0.01% 702

Other funds holding CBMG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Sumitomo Mitsui Trust Group's CBMG Position: Q2 2020 in Review

Sumitomo Mitsui Trust Group sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q2 2020, closing a stake of 476,673 shares — an estimated $7.54M sold.

Sumitomo Mitsui Trust Group first reported a position in CBMG in Q1 2019 and held it in 5 quarters. The position peaked at $8.73M in Q2 2019. 45 funds tracked by Wall St. Rank hold CBMG as of Q2 2020.

  • Sumitomo Mitsui Trust Group reported no remaining Cellular Biomedicine Group, Inc. position as of Q2 2020 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 476,673 Cellular Biomedicine Group, Inc. shares in Q2 2020, an estimated $7.54M.
  • Sumitomo Mitsui Trust Group first reported a position in Cellular Biomedicine Group, Inc. in Q1 2019 and held it in 5 quarters.
  • Sumitomo Mitsui Trust Group's Cellular Biomedicine Group, Inc. position peaked at $8.73M in Q2 2019.
  • 45 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q2 2020.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2020, filed 27 Jul 2020.